(Q39857571)

English

Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.

scientific article published on 14 May 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1

object named as

Jana Schwarzer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

René Hennig

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Volker Sandig

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

0 references

publication date

14 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

4325-4336

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19410619%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Production of influenza virus in cell cultures for vaccine preparation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

An avian cell line designed for production of highly attenuated viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Effects of glycosylation on the properties and functions of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Carbohydrates of influenza virus IV. Strain-dependent variations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Glycosylation of recombinant proteins: problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Intracellular functions of N-linked glycans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Glycopeptide components of influenza viral glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Lectin-resistant mutants of polarized epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Assembly of asparagine-linked oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Glycoproteins: what are the sugar chains for?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Neuraminidase Is Essential for Fowl Plague Virus Hemagglutinin to Show Hemagglutinating Activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Molecular characterization of influenza viruses circulating in Northern Italy during two seasons (2005/2006 and 2006/2007) of low influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Host cell-mediated variation in H3N2 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Sequence of an influenza virus hemagglutinin determined directly from a clinical sample

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.076

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39857571&oldid=2091609417"